UK markets open in 6 hours 4 minutes
NIKKEI 225
38,618.00 -302.26 (-0.78%) HANG SENG
19,376.53 +302.82 (+1.59%) CRUDE OIL
79.32 +0.09 (+0.11%) GOLD FUTURES
2,381.80 -3.70 (-0.16%) DOW
39,869.38 -38.62 (-0.10%) Bitcoin GBP
51,565.24 -653.02 (-1.25%)
INVA May 2024 15.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 03:28PM EDT. Market open.
| Previous close | 0.9500 |
| Open | 0.9000 |
| Bid | 0.8000 |
| Ask | 2.0000 |
| Strike | 15.00 |
| Expiry date | 2024-05-17 |
| Day's range | 0.9000 - 0.9000 |
| Contract range | N/A |
| Volume | |
| Open interest | 260 |
- GuruFocus.com
Innoviva Inc (INVA) Reports First Quarter 2024 Earnings: A Detailed Analysis
Strong Performance with Significant Growth in Net Product Revenue
Simply Wall St.Innoviva First Quarter 2024 Earnings: EPS: US$0.58 (vs US$0.51 in 1Q 2023)
Innoviva ( NASDAQ:INVA ) First Quarter 2024 Results Key Financial Results Revenue: US$77.5m (up 1.5% from 1Q 2023). Net...
Business WireInnoviva Reports First Quarter 2024 Financial Results; Highlights Recent Company Progress
BURLINGAME, Calif., May 08, 2024--Innoviva, Inc. (NASDAQ: INVA) ("Innoviva" or the "Company"), a diversified holding company with a core royalties portfolio, a leading critical care and infectious disease platform known as Innoviva Specialty Therapeutics ("IST"), and a portfolio of strategic investments in healthcare assets, today reported financial results for the first quarter ended March 31, 2024, and highlighted select corporate achievements.
© 2024 Yahoo. All rights reserved.